07:00 , Aug 24, 2015 |  BC Week In Review  |  Company News

Eisai sales and marketing update

Eisai’s Eidia Co. Ltd. subsidiary launched Stacia Cleia Pivka-II in Japan with an automated immunoanalyzer from LSI Medience Co. Ltd. (Tokyo, Japan) to measure hepatocellular carcinoma (HCC) marker prothrombin induced in vitamin K absence-II (...
08:00 , Mar 7, 2011 |  BC Week In Review  |  Clinical News

UTASWako i30 regulatory update

FDA granted 510(k) clearance for Wako's uTASWako i30 automated instrument for use with its FDA-cleared alpha-fetoprotein L3 (AFP-L3) and des-gamma-carboxy prothrombin (DCP) in vitro diagnostics to assess the risk of developing hepatocellular carcinoma (HCC) in...